Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Beam Therapeutics Inc. (NASDAQ: BEAM - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the sixteen ratings firms that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eleven have given a buy rating and one